These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10773735)

  • 1. Efficacy of an inactivated vaccine for equine herpesvirus type 1 in a novel hamster model.
    Skinner GR; Davies J
    Intervirology; 2000; 43(1):27-35. PubMed ID: 10773735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and virological evaluation of the efficacy of an inactivated EHV1 and EHV4 whole virus vaccine (Duvaxyn EHV1,4). Vaccination/challenge experiments in foals and pregnant mares.
    Heldens JG; Hannant D; Cullinane AA; Prendergast MJ; Mumford JA; Nelly M; Kydd JH; Weststrate MW; van den Hoven R
    Vaccine; 2001 Jul; 19(30):4307-17. PubMed ID: 11457558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A protective effect of epidermal powder immunization in a mouse model of equine herpesvirus-1 infection.
    Kondo T; McGregor M; Chu Q; Chen D; Horimoto T; Kawaoka Y
    Virology; 2004 Jan; 318(1):414-9. PubMed ID: 14972566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination of foals and pregnant mares with Duvaxyn EHV1, 4 vaccine.
    Studdert MJ
    Vaccine; 2002 Jan; 20(7-8):992. PubMed ID: 11803056
    [No Abstract]   [Full Text] [Related]  

  • 5. Monoclonal antibodies with neutralizing activity to equine herpesvirus 1.
    Shimizu M; Satou K; Nishioka N
    Arch Virol; 1989; 104(1-2):169-74. PubMed ID: 2538111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equine rhinopneumonitis vaccine: immunogenicity and safety in foals.
    Purdy CW; Porter RC; Ford SJ
    Am J Vet Res; 1978 May; 39(5):745-52. PubMed ID: 215062
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunologic relationships between equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus).
    Fitzpatrick DR; Studdert MJ
    Am J Vet Res; 1984 Oct; 45(10):1947-52. PubMed ID: 6208822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equine herpesvirus-1 strain KyA, a candidate vaccine strain, reduces viral titers in mice challenged with a pathogenic strain, RacL.
    Colle CF; Tarbet EB; Grafton WD; Jennings SR; O'Callaghan DJ
    Virus Res; 1996 Aug; 43(2):111-24. PubMed ID: 8864201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a monoclonal antibody blocking ELISA for the detection of antibodies against both equine herpesvirus type 1 (EHV1) and equine herpesvirus type 4 (EHV4).
    van Maanen C; de Boer-Luijtze E; Terpstra C
    Vet Microbiol; 2000 Jan; 71(1-2):37-51. PubMed ID: 10665532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that use of an inactivated equine herpesvirus vaccine induces serum cytotoxicity affecting the equine arteritis virus neutralisation test.
    Newton JR; Geraghty RJ; Castillo-Olivares J; Cardwell JM; Mumford JA
    Vaccine; 2004 Sep; 22(29-30):4117-23. PubMed ID: 15364465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
    Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
    Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).
    Goodman LB; Wagner B; Flaminio MJ; Sussman KH; Metzger SM; Holland R; Osterrieder N
    Vaccine; 2006 Apr; 24(17):3636-45. PubMed ID: 16513225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
    Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against lethal equine herpes virus type 1 (subtype 1) infection in hamsters by immune stimulating complexes (ISCOMs) containing the major viral glycoproteins.
    Cook RF; O'Neill T; Strachan E; Sundquist B; Mumford JA
    Vaccine; 1990 Oct; 8(5):491-6. PubMed ID: 2174599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of a chemically inactivated, adjuvanted vaccine to control abortigenic infection of mares by equine herpesvirus I.
    Bryans JT; Allen GP
    Dev Biol Stand; 1982; 52():493-8. PubMed ID: 6299858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of equine herpesvirus type 1 (EHV1) and equine rhinovirus type 1 (ERhV1) following inactivation by betapropiolactone (BPL) and ultraviolet (UV) light.
    Campbell TM; Studdert MJ; Blackney MH
    Vet Microbiol; 1982 Dec; 7(6):535-44. PubMed ID: 6301141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody and cellular immune responses of naïve mares to repeated vaccination with an inactivated equine herpesvirus vaccine.
    Wagner B; Goodman LB; Babasyan S; Freer H; Torsteinsdóttir S; Svansson V; Björnsdóttir S; Perkins GA
    Vaccine; 2015 Oct; 33(42):5588-5597. PubMed ID: 26384446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of equid herpesvirus 1-specific, CD8+, cytotoxic T lymphocyte precursor frequencies in ponies.
    O'Neill T; Kydd JH; Allen GP; Wattrang E; Mumford JA; Hannant D
    Vet Immunol Immunopathol; 1999 Sep; 70(1-2):43-54. PubMed ID: 10507286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB).
    Osterrieder N; Wagner R; Brandmüller C; Schmidt P; Wolf H; Kaaden OR
    Virology; 1995 Apr; 208(2):500-10. PubMed ID: 7747423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and antibody responses to equine herpesviruses 1 and 4 following vaccination of horses with modified-live and inactivated viruses.
    Ellis JA; Bogdan JR; Kanara EW; Morley PS; Haines DM
    J Am Vet Med Assoc; 1995 Mar; 206(6):823-32. PubMed ID: 7538990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.